|
[1]
|
AlHussaini, K.I. (2023) Microscopic Colitis: A Review Article. Cureus, 15, e47150. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hu, S., Zhao, R., Xu, Y., Gu, Z., Zhu, B. and Hu, J. (2024) Orally-Administered Nanomedicine Systems Targeting Colon Inflammation for the Treatment of Inflammatory Bowel Disease: Latest Advances. Journal of Materials Chemistry B, 12, 13-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hung, T. H., Wang, C. Y. and Lee, H. F. (2023) Update in Diagnosis and Management of Irritable Bowel Syndrome. Tzu Chi Medical Journal, 35, 306-311. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Loveikyte, R., Bourgonje, A.R., van Goor, H., Dijkstra, G. and van der Meulen-de Jong, A.E. (2023) The Effect of Iron Therapy on Oxidative Stress and Intestinal Microbiota in Inflammatory Bowel Diseases: A Review on the Conundrum. Redox Biology, 68, Article ID: 102950. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Schirmer, M., Garner, A., Vlamakis, H. and Xavier, R.J. (2019) Microbial Genes and Pathways in Inflammatory Bowel Disease. Nature Reviews Microbiology, 17, 497-511. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lloyd-Price, J., Arze, C., Ananthakrishnan, A.N., Schirmer, M., Avila-Pacheco, J., Poon, T.W., et al. (2019) Multi-Omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases. Nature, 569, 655-662. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Roy, S. and Dhaneshwar, S. (2023) Role of Prebiotics, Probiotics, and Synbiotics in Management of Inflammatory Bowel Disease: Current Perspectives. World Journal of Gastroenterology, 29, 2078-2100. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B. and Margolles, A. (2017) Bifidobacteria and Their Health-Promoting Effects. Microbiology Spectrum, 5. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Li, M.Y., Luo, H.J., Wu, X., Liu, Y.H., Gan, Y.X., Xu, N., Zhang, Y.M., Zhang, S.H., Zhou, C.L., Su, Z.R., Huang, X.Q., and Zheng, X.B. (2020) Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways. Frontiers in Pharmacology, 10, Article 1552. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Luo, S., Wen, R., Wang, Q., Zhao, Z., Nong, F., Fu, Y., Huang, S., Chen, J., Zhou, L. and Luo, X. (2019) Rhubarb Peony Decoction Ameliorates Ulcerative Colitis in Mice by Regulating Gut Microbiota to Restoring Th17/Treg Balance. Journal of Ethnopharmacology, 231, 39-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Yuan, Z., Yang, L., Zhang, X., Ji, P. and Wei, Y. (2020) Therapeutic Effect of N-Butanol Fraction of Huang-Lian-Jie-Du Decoction on Ulcerative Colitis and Its Regulation on Intestinal Flora in Colitis Mice. Biomedicine & Pharmacotherapy, 121, Article ID: 109638. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Liu, Y., Li, B.G., Su, Y.H., Zhao, R.X., Song, P., Li, H., Cui, X.H., Gao, H.M., Zhai, R.X., Fu, X.J. and Ren, X. (2022) Potential Activity of Traditional Chinese Medicine against Ulcerative Colitis: A Review. Journal of Ethnopharmacology, 289, Article ID: 115084. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhang, B., Liu, K., Yang, H., Jin, Z., Ding, Q. and Zhao, L. (2022) Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Frontiers in Cellular and Infection Microbiology, 12, Article 855075. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Nogales, C., Mamdouh, Z.M., List, M., Kiel, C., Casas, A.I. and Schmidt, H.H.H.W. (2022) Network Pharmacology: Curing Causal Mechanisms Instead of Treating Symptoms. Trends in Pharmacological Sciences, 43, 136-150. [Google Scholar] [CrossRef] [PubMed]
|